Skin cancer detection devices sales will expand through 2035, with handheld devices holding 58.3% share of the modality segment in 2025. Hospitals hold 53.2% share of the end user segment in 2025. The market is expected to reach USD 1,073.8 million in 2025 and USD 3,133.8 million by 2035.